Health
Ena Respiratory nasal spray shows promise against Covid-19 – Pharmaceutical Technology
Australian biotech company Ena Respiratory has said that its nasal spray has significantly mitigated Covid-19 virus levels in the nose and throat in a study on …
Australian biotech company Ena Respiratory said that its nasal spray significantly mitigated Covid-19 virus levels in the nose and throat in a study on animals.
The treatment could potentially enhance the human immune system against common colds and flu.
INNA-051 is a synthetic small molecule self-administered via a nasal spray once or twice a week, used alone or along with vaccine programmes for Covid-19.
Researchers performed the study, published on biomedical prepublication research site …
-
Business22 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General18 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Business23 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?
-
Noosa News13 hours agoThe only person detained at Brisbane’s Palestine rally